|
2025-05-20 |
2025-05-16 |
PP
Planned purchase
|
Baldry Mark
Chief Commercial Officer
Officer
|
1,032
+4.2%
2.48
USD 2,561
|
1,032
+4.2%
|
2.48
|
USD 2,561
|
|
|
2025-01-27 |
2025-01-24 |
PS
Planned sale
|
Baldry Mark
Chief Commercial Officer
Officer
|
29,159
-23.7%
0.45
USD 13,241
|
29,159
-23.7%
|
0.45
|
USD 13,241
|
|
|
2025-01-27 |
2025-01-24 |
PS
Planned sale
|
Ragan Paula
President and CEO
Executive Director
|
76,473
-6.6%
0.45
USD 34,719
|
76,473
-6.6%
|
0.45
|
USD 34,719
|
|
|
2025-01-27 |
2025-01-24 |
PS
Planned sale
|
Arbet-Engels Christophe
Chief Medical Officer
Officer
|
11,624
-45.0%
0.45
USD 5,284
|
11,624
-45.0%
|
0.45
|
USD 5,284
|
|
|
2025-01-27 |
2025-01-24 |
PS
Planned sale
|
DiBiase Mary
Chief Operating Officer
Officer
|
22,258
-4.3%
0.45
USD 10,094
|
22,258
-4.3%
|
0.45
|
USD 10,094
|
|
|
2025-01-27 |
2025-01-24 |
PS
Planned sale
|
Mostafa Adam S.
Chief Financial Officer
Officer
|
74,773
-100.0%
0.45
USD 33,947
|
74,773
-100.0%
|
0.45
|
USD 33,947
|
|
|
2025-02-14 |
2024-11-15 |
PP
Planned purchase
|
Baldry Mark
Chief Commercial Officer
Officer
|
13,404
+11.6%
0.34
USD 4,598
|
13,404
+11.6%
|
0.34
|
USD 4,598
|
|
|
2024-11-19 |
2024-11-15 |
PS
Planned sale
|
Ragan Paula
President and CEO
Executive Director
|
31,897
-3.1%
0.39
USD 12,583
|
31,897
-3.1%
|
0.39
|
USD 12,583
|
|
|
2024-10-16 |
2024-10-15 |
PS
Planned sale
|
Ragan Paula
President and CEO
Executive Director
|
31,897
-3.0%
0.56
USD 17,926
|
31,897
-3.0%
|
0.56
|
USD 17,926
|
|
|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
Taveras Arthur
Chief Scientific Officer
Officer
|
76,920
-16.5%
0.56
USD 43,306
|
76,920
-16.5%
|
0.56
|
USD 43,306
|
|
|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
Baldry Mark
Chief Commercial Officer
Officer
|
11,127
-18.7%
0.58
USD 6,506
|
11,127
-18.7%
|
0.58
|
USD 6,506
|
|
|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
Ragan Paula
President and CEO
Executive Director
|
239,436
-18.5%
0.55
USD 131,522
|
239,436
-18.5%
|
0.55
|
USD 131,522
|
|
|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
Mostafa Adam S.
Chief Financial Officer
Officer
|
230,645
-100.0%
0.55
USD 126,901
|
230,645
-100.0%
|
0.55
|
USD 126,901
|
|
|
2024-10-08 |
2024-10-07 |
PS
Planned sale
|
DiBiase Mary
Chief Operating Officer
Officer
|
67,695
-13.0%
0.57
USD 38,329
|
67,695
-13.0%
|
0.57
|
USD 38,329
|
|
|
2024-09-11 |
2024-09-09 |
S
Sale
|
DiBiase Mary
Chief Operating Officer
Officer
|
2,642
-0.9%
0.66
USD 1,738
|
2,642
-0.9%
|
0.66
|
USD 1,738
|
|
|
2025-02-14 |
2024-05-17 |
PP
Planned purchase
|
Baldry Mark
Chief Commercial Officer
Officer
|
21,646
+23.0%
0.68
USD 14,654
|
21,646
+23.0%
|
0.68
|
USD 14,654
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
Ragan Paula
President and CEO
Executive Director
|
49,678
-6.1%
0.88
USD 43,856
|
49,678
-6.1%
|
0.88
|
USD 43,856
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
Mostafa Adam S.
Chief Financial Officer
Officer
|
52,500
-100.0%
0.88
USD 46,347
|
52,500
-100.0%
|
0.88
|
USD 46,347
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
DiBiase Mary
Chief Operating Officer
Officer
|
15,409
-5.0%
0.88
USD 13,591
|
15,409
-5.0%
|
0.88
|
USD 13,591
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
Taveras Arthur
Chief Scientific Officer
Officer
|
14,235
-5.7%
0.88
USD 12,552
|
14,235
-5.7%
|
0.88
|
USD 12,552
|
|
